RxDoctor Payments Data

Julie Stein

Nurse Practitioner · Dyer, INNPI 1437621505

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 70.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $1,528 and has fallen 55.3% since, to $684 in 2025. Among nurse practitioner clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,376in general payments, 2019–2025

Across 78 payments — averaging $56.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Spinal Simplicity, LLC$503
  • Boston Scientific$383
  • E.r. Squibb & Sons, L.L.C.$116
  • Nalu Medical, Inc.$102
  • Inari Medical, Inc.$94
  • plus $107 from 2 others

What the payments were for

  • Food & beverage$4,376100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,376 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana →

Medicare billing

Part B allowed, 2024
$134,346
Medicare patients
362
Services billed
1,415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,477$55,952
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen864$21,874
Pregabalin199$11,052
Gabapentin486$5,047
Naloxone Hcl84$3,997
Lidocaine41$2,869
Oxycodone Hcl121$2,011
Morphine Sulfate79$1,742
Morphine Sulfate ErMorphine Sulfate74$1,533
Cyclobenzaprine Hcl217$1,513
Tramadol Hcl212$1,447
Tizanidine Hcl224$1,434
Baclofen67$1,257
Methocarbamol62$789
Acetaminophen-CodeineAcetaminophen With Codeine41$588

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Dyer

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →